Influenza A Viral Infections Drug Development Pipeline Review and Insight, 2018

Posted on 2018-05-09 by Mark Hub in Pharmaceuticals // 0 Comments

Market Research HUB

Albany, US, 2018-May-09 — /EPR Network/ — A fresh report has been added to the wide database of Market Research Hub (MRH). The research study is titled “Influenza A Viral Infections Drug Development Pipeline Review, 2018” which encloses important data about the Influenza A Viral Infections Drug Development. This report provides an overview of the pipeline landscape for influenza A viral infections. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for influenza A H3N2, H1N1, H5N1 and H7N9 subtype infections, and features dormant and discontinued products.

Request Free Sample Report- https://www.marketresearchhub.com/enquiry.php?type=S&repid=1763912

Influenza is an acute infection of the respiratory tract that predominately affects the nose, throat and bronchi, and less commonly the lungs. Influenza viruses have a single-stranded segmented RNA genome. They belong to the family Orthomyxoviridae, and are categorized into three genera based on their core proteins A, B and C. Influenza A and B viruses are responsible for the majority of symptomatic cases of influenza in humans.

Influenza A viruses can be further categorized based on their expression of two viral surface proteins: hemagglutinin (H); and neuraminidase (N). These viruses are known to have high mutation rates, with frequent changes to the viral protein structure.

Scope

– Which companies are the most active within the pipeline for influenza A viral infections?
– Which pharmaceutical approaches are most prominent at each stage of the pipeline and within each indication?
– To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
– What are the most important R&D milestones and data publications to have happened within this field?

Browse Full Report with TOC- https://www.marketresearchhub.com/report/influenza-a-viral-infections-drug-development-pipeline-review-2018-report.html

Reasons to buy

– Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
– Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
– Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
– Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Table of Contents

1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 8
2 Introduction 10
2.1 Influenza A Viral Infections Report Coverage 10
2.2 Influenza A Virus, H3N2 Subtype Infections Overview 10
2.3 Influenza A Virus, H1N1 Subtype Infections Overview 10
2.4 Influenza A Virus, H5N1 Subtype Infections Overview 10
2.5 Influenza A Virus, H7N9 Subtype Infections Overview 10
3 Therapeutics Development 11
3.1 Influenza A Virus, H3N2 Subtype Infections 11
3.2 Influenza A Virus, H1N1 Subtype Infections 19
3.3 Influenza A Virus, H5N1 Subtype Infections 31
3.4 Influenza A Virus, H7N9 Subtype Infections 41
4 Therapeutics Assessment 48
4.1 Influenza A Virus, H3N2 Subtype Infections 48
4.2 Influenza A Virus, H1N1 Subtype Infections 55
4.3 Influenza A Virus, H5N1 Subtype Infections 62
4.4 Influenza A Virus, H7N9 Subtype Infections 69
5 Companies Involved in Therapeutics Development 75
5.1 Influenza A Virus, H3N2 Subtype Infections 75
5.2 Influenza A Virus, H1N1 Subtype Infections 89
5.3 Influenza A Virus, H5N1 Subtype Infections 114
5.4 Influenza A Virus, H7N9 Subtype Infections 130
6 Dormant Projects 140
6.1 Influenza A Virus, H3N2 Subtype Infections 140
6.2 Influenza A Virus, H1N1 Subtype Infections 142
6.3 Influenza A Virus, H5N1 Subtype Infections 146
6.4 Influenza A Virus, H7N9 Subtype Infections 151
7 Discontinued Products 152
7.1 Influenza A Virus, H3N2 Subtype Infections 152
7.2 Influenza A Virus, H1N1 Subtype Infections 153
7.3 Influenza A Virus, H5N1 Subtype Infections 153
8 Product Development Milestones 154
8.1 Influenza A Virus, H3N2 Subtype Infections 154
8.2 Influenza A Virus, H1N1 Subtype Infections 160
8.3 Influenza A Virus, H5N1 Subtype Infections 174
…..

Enquire about this Report- https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1763912

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us

90 State Street,
Albany, NY 12207,
United States
Toll Free: – 800-998-4852 (US-Canada)
Email:- press@marketresearchhub.com
Website:- https://www.marketresearchhub.com/

Matched content

Editor’s pick